Andrews AL, et al. - The potential of asthma medication ratio (AMR) to be a near real-time risk assessment tool to detect children with asthma at high-risk for exacerbation, was assessed in this retrospective study involving a longitudinal testing of the AMR (#of controller medication claims/(# of controller medication claims + # of rescue medication claims)) in Medicaid-funded asthmatic pediatric population. Researchers analyzed 2013–2014 Truven Health Medicaid data. Overall 214,452 eligible children, with mean age of 7.8 years, were included. In this study, the reliability of the AMR as a predictor of exacerbations was proved among Medicaid-insured children with asthma.